U S Physical Therapy INC /NV Form 4 insider transactions

Director Peter Minan acquired 780 shares of U.S. Physical Therapy, Inc. common stock through open market purchases.

Director Regg E. Swanson filed an amendment to correct the reported transaction price of a restricted stock grant.

Director Anne Motsenbocker filed an amendment to correct the reported transaction price of a restricted stock grant from $61.61 to $0.00.

Director Peter Francis Minan filed an amendment to correct the reported transaction price of a restricted stock grant from $61.61 to $0.00.

Director Kathleen A. Gilmartin filed an amendment to correct the reported transaction price of a restricted stock grant.

Anne Motsenbocker, a Director at U.S. Physical Therapy Inc., acquired 2,306 shares of common stock on May 19, 2026, as part of a restricted stock grant.

Regg E. Swanson, a Director at US Physical Therapy Inc., has acquired 2,306 shares of common stock.

Peter Francis Minan, a Director at US Physical Therapy Inc., acquired 2,306 shares of common stock on May 19, 2026, as part of a restricted stock grant.

Bernard A. Harris Jr., a director at U.S. Physical Therapy Inc., acquired 2,306 shares of common stock on May 19, 2026, as part of a restricted stock grant.

Director Kathleen Gilmartin acquired 2,306 shares of U.S. Physical Therapy Inc. common stock on May 19, 2026, as part of a restricted stock grant.

U.S. Physical Therapy's COO, Graham D. Reeve, reported the sale of 662 common shares at a weighted average price of $78.86, while retaining a significant holding.

U.S. Physical Therapy's Chairman and CEO, Christopher J. Reading, was granted 25,000 shares of restricted common stock, aligning his interests with long-term shareholder value.

U.S. Physical Therapy's President and COO, Eric Joseph Williams, was granted 15,000 restricted shares of common stock, vesting through March 2030.

U.S. Physical Therapy COO Graham D. Reeve was granted 10,000 shares of restricted common stock, increasing his direct beneficial ownership.

U.S. Physical Therapy's EVP, General Counsel & Secretary, Richard Binstein, was granted 10,000 restricted common shares.

U.S. Physical Therapy's CFO, Carey P. Hendrickson, received a grant of 10,000 restricted common shares, increasing total beneficial ownership to 37,808 shares.

U.S. Physical Therapy COO Graham D. Reeve sold 743 shares of common stock at a weighted average price of $71.01 per share.

Kathleen A. Gilmartin, a director at U.S. Physical Therapy Inc., purchased 4,000 shares of common stock at $69 per share.

U.S. Physical Therapy Director Nancy Ham sold 600 shares of common stock at $81.71 per share, as disclosed in a recent SEC Form 4 filing.

U.S. Physical Therapy's President and COO, Eric Joseph Williams, sold 1,000 shares of common stock for $85.25 per share under a pre-arranged trading plan.

U.S. Physical Therapy's Chairman and CEO, Christopher J. Reading, sold 2,000 shares of common stock for $83.53 per share, while still holding over 114,000 shares.

U.S. Physical Therapy's Chief Financial Officer, Carey P. Hendrickson, reported the sale of 698 shares of common stock for $86.11 per share.

U.S. Physical Therapy COO Graham D. Reeve sold 763 shares of common stock for approximately $84.97 per share under a pre-arranged plan.

U.S. Physical Therapy Inc. EVP Richard Binstein sold 2,000 shares of common stock for approximately $170,000.

U.S. Physical Therapy's COO, Graham D. Reeve, sold 1,792 shares of common stock for $86.57 per share, executed under a Rule 10b5-1 plan.

Nancy Ham, a Director at U.S. Physical Therapy Inc. (USPH), reported the sale of 400 shares of common stock at a weighted average price of $78.01 per share.

Graham Reeve, COO of U.S. Physical Therapy, reports the sale of 530 shares of common stock at an average price of $78.08 and updates his beneficial ownership, including restricted stock grants.

Eric Joseph Williams, President and COO of U.S. Physical Therapy, Inc., sold 633 shares of common stock at an average price of $78.09.

Director Anne Motsenbocker acquired 1,882 shares of restricted stock in U.S. Physical Therapy, Inc., according to a recent SEC filing.

Kathleen Gilmartin, a director of U.S. Physical Therapy, reported the acquisition of 1,882 shares of restricted stock on May 20, 2025.